<- Go Home
Genomma Lab Internacional, S.A.B. de C.V.
Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and improvement products, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, infant nutrition, and others. Genomma Lab Internacional, S.A.B. de C.V. was incorporated in 1996 and is based in Mexico City, Mexico.
Market Cap
MXN 23.2B
Volume
3.7M
Cash and Equivalents
MXN 2.3B
EBITDA
MXN 4.3B
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
MXN 11.9B
Profit Margin
64.12%
52 Week High
MXN 29.18
52 Week Low
MXN 13.90
Dividend
3.38%
Price / Book Value
2.00
Price / Earnings
10.87
Price / Tangible Book Value
4.33
Enterprise Value
MXN 27.4B
Enterprise Value / EBITDA
6.39
Operating Income
MXN 4.0B
Return on Equity
20.33%
Return on Assets
11.11
Cash and Short Term Investments
MXN 2.3B
Debt
MXN 6.5B
Equity
MXN 11.6B
Revenue
MXN 18.6B
Unlevered FCF
MXN 1.1B
Sector
Pharmaceuticals
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium